Search the Cancer Center site

Search the Cancer Center site

Home
About
About

Located in Worcester, Massachusetts, the UMass Cancer Center is committed to providing exceptional patient care, conducting cutting-edge research at the highest level, offering excellence in education and training, and serving as an educational resource and advocate for the Central Massachusetts community.
Patients
Patients

Expert Cancer Care in Central Massachusetts

We offer comprehensive cancer care for all childhood and adult cancers, combining state-of-the-art treatments with compassionate support for patients and their families.
Clinicians
Research
Research

Cutting-Edge Cancer Research

We carry out front-line research in basic, translational, clinical and population-based discovery to find newer, better methods for the prevention, detection, diagnosis, and treatment of cancer.
Education
Education

World Class Medical and Scientific Education

The UMass Cancer Center is dedicated to training the next generation of cancer researchers, clinicians and physician-scientists.
Outreach

Additional Resources

Cancer Nexus Blog

Read up on the Center's latest developments in cancer research, screening and prevention, as well as innovations in cancer detection and treatment.

Oct 7, 2022

Stopping Blood Cancer Before It Starts

Shyam Patel, MD, PhD, explains a new method for detecting blood cancer before it takes root.

Read more
Dec 20, 2021

Developing Computational Methods to Detect Fusion Circular RNAs in Cancer

UMass Cancer Center and PQHS fund a pilot study to develop new bioinformatic tools to identify fusion circRNAs in cancer

Read more
May 27, 2021

Combating drug resistance in melanoma

Ceol 's lab have developed a drug that targets this factor and is currently testing whether it can combat drug resistance when used in combination with current therapies.

Read more
May 25, 2021

Teaming Up to Find New Ways to Treat Melanoma

UMass Cancer Center researchers are developing new therapeutic treatments for melanoma that can be used alone or in combination with current therapies

Read more
Mar 16, 2021

UMass Cancer Center offers a Phase III Study of Maintenance Drug Therapy for Multiple Myeloma

Aims to determine if adding daratumumab results in improved overall survival, improved response and MRD negativity

Read more